- Report
- April 2023
- 120 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- April 2023
- 115 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- August 2022
- 125 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- August 2022
- 116 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- January 2022
- 112 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- September 2023
- 140 Pages
Global
From €3435EUR$3,599USD£2,878GBP
- Report
- April 2023
- 147 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- April 2021
- 120 Pages
Global
€20996EUR$22,000USD£17,592GBP
- Report
- January 2024
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- November 2023
- 120 Pages
North America
From €3293EUR$3,450USD£2,759GBP
- Report
- October 2023
- 176 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- August 2023
- 205 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- January 2023
- 216 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- November 2022
- 140 Pages
Europe
From €3293EUR$3,450USD£2,759GBP
- Report
- November 2022
- 128 Pages
North America
From €3293EUR$3,450USD£2,759GBP
- Report
- November 2021
- 183 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- February 2024
- 124 Pages
Global
From €4056EUR$4,250USD£3,398GBP
- Report
- December 2021
- 124 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- November 2023
- 140 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- April 2022
- 114 Pages
Global
From €4247EUR$4,450USD£3,558GBP

The Blood Cell market is a subset of the biotechnology industry that focuses on the development of products and services related to the study and manipulation of blood cells. This includes the production of blood cell-based therapeutics, such as monoclonal antibodies, as well as the development of diagnostic tests and treatments for blood-related diseases. Blood cell research is also used to develop treatments for cancer, autoimmune diseases, and other conditions.
The Blood Cell market is a rapidly growing sector of the biotechnology industry, with new products and services being developed to meet the needs of patients and healthcare providers. Companies in this market are focused on developing innovative technologies and treatments to improve patient outcomes and reduce healthcare costs.
Some of the companies in the Blood Cell market include AbbVie, Amgen, AstraZeneca, Biogen, Celgene, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, and Regeneron Pharmaceuticals. Show Less Read more